ALIM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALIM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-03-28), Alimera Sciences's 12-1 Month Momentum % is 89.19%.
The industry rank for Alimera Sciences's 12-1 Month Momentum % or its related term are showing as below:
For the Drug Manufacturers - Specialty & Generic subindustry, Alimera Sciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Alimera Sciences's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Alimera Sciences's 12-1 Month Momentum % falls into.
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum % | = | ( Price 1-month ago | / | Price 12-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alimera Sciences (NAS:ALIM) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of Alimera Sciences's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Margaret Pax | director | 6310 TOWN SQUARE, SUITE 400, ALPHARETTA GA 30005 |
John Snisarenko | director | C/O ALIMERA SCIENCES, INC., 6120 WINDWARD PARKWAY, SUITE 290, ALPHARETTA GA 30005 |
Pizzo Peter J. Iii | director | 6120 WINDWARD PARKWAY, SUITE 290, ALPHARETTA GA 30005 |
Erin Parsons | director | 97 WILLISTON RD, BROOKLINE MA 02445 |
Caligan Partners Lp | 10 percent owner | 515 MADISON AVENUE, 8TH FLOOR, NEW YORK NY 10022 |
Ross D Demont | director | 51 PICKWICK ROAD, NEWTON MA 02465 |
C. Daniel Myers | other: Chairman Emeritus | 6120 WINDWARD PARKWAY, SUITE 290, ALPHARETTA GA 30005 |
David Edward Johnson | 10 percent owner | 590 MADISON AVENUE, NEW YORK NY 10022 |
Velan Capital Master Fund Lp | 10 percent owner | 1055B POWERS PLACE, ALPHARETTA GA 30009 |
Velan Capital Management Llc | 10 percent owner | 1055B POWERS PLACE, ALPHARETTA GA 30009 |
Velan Capital Holdings Llc | 10 percent owner | 1055B POWERS PLACE, ALPHARETTA GA 30009 |
Adam Morgan | director | 1055B POWERS PLACE, ALPHARETTA GA 30009 |
Velan Capital Investment Management Lp | 10 percent owner | 1055B POWERS PLACE, ALPHARETTA GA 30009 |
Velan Capital Spv I Llc | 10 percent owner | 1055B POWERS PLACE, ALPHARETTA GA 30009 |
Balaji Venkataraman | 10 percent owner | FIRST HORIZON PHARMACEUTICAL CORP, 660 HEMBREE PKWY STE 106, ROSWELL GA 30076 |
From GuruFocus
By sperokesalga 04-20-2023
By sperokesalga 05-08-2023
By sperokesalga 03-24-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.